Ensemble-Learning and Feature Selection Techniques for Enhanced Antisense Oligonucleotide Efficacy Prediction in Exon

Alex Zhu1,2, Shuntaro Chiba3, Yuki Shimizu4

  • 1Phillips Academy, Andover, MA 01810, USA.

Pharmaceutics
|July 29, 2023
PubMed
Summary

This study introduces an efficient machine-learning approach to predict antisense oligonucleotide (ASO) efficacy for exon skipping, significantly reducing computation time and improving accuracy for gene therapy development.